Journals / Bakırköy Tıp Dergisi / 2021 / Cilt: 17 - Sayı: 4

Association of TG/HDL Ratio with Cardiovascular Mortality in Patients Who are on Hemodialysis

Hemodiyalize Giren Son Dönem Böbrek Yetersizliği Hastalarında TG/HDL Oranı ile Kardiyovasküler Ölüm Arasındaki İlişki

Pages
386–391
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Therefore, it may significantly benefit in optimizing cardiovascular risk management and treatment goals in these patients.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: There is a relation between triglyceride/high-density lipoprotein (TG/HDL) ratio, and cardiovascular and all-cause mortality.
📊
Key Findings & Data:Methods: This study included 344 cases who were aged ≥18 years and on hemodialysis.
💡
Conclusion & Impact:Therefore, it may significantly benefit in optimizing cardiovascular risk management and treatment goals in these patients.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: There is a relation between triglyceride/high-density lipoprotein (TG/HDL) ratio, and cardiovascular and all-cause mortality. No study has been conducted on this relationship in cases with end-stage renal disease who are on hemodialysis in Turkey. Therefore, we aimed to see the relation between TG/HDL ratio and cardiovascular mortality in hemodialysis patients. Methods: This study included 344 cases who were aged ≥18 years and on hemodialysis. These cases were divided into two groups as cardiovascular death (n=31) and survivors (n=313). Primary endpoint of this study was cardiovascular mortality. Results: Among 344 patients, 74.1% were males, and the mean age was 43.7±12.6 years. Dialysis duration was 1.1 (3.1) years, and the total follow-up duration was 5.9 (2.9) years. TG/HDL ratio was similar in both groups (p>0.05). Age [human resource (HR): 1.02, 95% confidence interval (CI): (1,055-1.09), p=0.02], HbA1c [HR: 1,292, 95% CI: (1,080-1,546), p=0.05], and TG/HDL ratio [HR: 1,078, 95% CI: (1,009-1.51), p=0.026] were independent predictors of cardiovascular mortality. Kaplan-Meier curves revealed that cardiovascular mortality was higher in the group using fenofibrate [p (log-rank) =0.01]. Conclusion: TG/HDL ratio is an inexpensive, simply applicable tool that may predict cardiovascular mortality in hemodialysis patients. Therefore, it may significantly benefit in optimizing cardiovascular risk management and treatment goals in these patients.

Özet

Amaç: Trigliserit/yüksek yoğunluklu lipoprotein (TG/HDL) oranı ile kardiyovasküler ve tüm nedenlere bağlı ölüm arasında bir ilişki olduğu bilinmektedir. Ülkemizde hemodiyalize giren son dönem böbrek yetersizliği hastalarında bu ilişkiyi inceleyen çalışma yapılmamıştır. Bu nedenle çalışmamızda hemodiyaliz hastalarında TG/HDL oranı ile kardiyovasküler ölüm arasında bulunan ilişkiyi incelemeyi amaçladık. Gereç ve Yöntem: Çalışmaya 18 yaş ve üzerinde, hemodiyalize giren son dönem böbrek yetersizliği tanısı almış 344 hasta dahil edildi. Hastalar kardiyovasküler sebeplerle ölen (n=31) ve sağ kalan (n=313) hasta olarak ikiye bölündü. Çalışmanın birincil sonlanım noktası kardiyovasküler ölüm idi. Bulgular: Çalışmaya alınan 343 hastanın %74,1’i erkek olup, yaş ortalaması 43,7±12,6 idi Ortalama diyaliz süresi 1,1 (3,1) yıl, toplam takip süresi ise 5,9 (2,9) yıldı. TG/HDL oranı her iki grupta da benzerdi (p>0,05). Yaş [human kaynak (HR): 1,02 %95 güven aralığı (CI): (1.055-1,09), p=0,02], HbA1c [HR: 1.292 %95 CI: (1.080-1.546), p=0,05 ] ve TG/HDL oranı [HR: 1.078 %95 CI: (1.009-1,51), p=0,026], kardiyovasküler ölümün bağımsız öngörücüleri olarak bulundu. Kaplan-Meier eğrileri, fenofibrat kullanan grupta kardiyovasküler mortalitenin anlamlı olarak daha yüksek olduğunu ortaya koydu [p (log-rank) =0,01]. Sonuç: TG/HDL oranı hemodiyaliz hastalarında kardiyovasküler mortaliteyi öngörebilen ucuz, kolay uygulanabilir bir yöntemdir. Bu nedenle, bu hastaların kardiyovasküler risk yönetiminde ve tedavi hedeflerini optimize etmede önemli bir fayda sağlayacaktır.

🔖

Cite This Article

Karabulut, U., Yılmaz, G. (2022). Association of TG/HDL Ratio with Cardiovascular Mortality in Patients Who are on Hemodialysis. Bakırköy Tıp Dergisi, Cilt: 17 - Sayı: 4, 386–391. https://ajindex.com/articles/459983

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. US Renal Data System: USRDS 2015 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2015
  2. Neuen BL, Leather N, Greenwood AM, Gunnarsson R, Cho Y, Mantha ML. Neutrophil-lymphocyte ratio predicts cardiovascular and all-cause mortality in hemodialysis patients. Ren Fail 2016;38:70-6
  3. Chang YM, Huang YT, Chen IL, Yang CL, Leu SC, Su HL, et al. Heart rate variability as an independent predictor for 8-year mortality among chronic hemodialysis patients. Sci Rep 2020;10:881
  4. Fitzpatrick J, Sozio SM, Jaar BG, Estrella MM, Segev DL, Parekh RS, et al. Frailty, body composition and the risk of mortality inincident hemodialysis patients: the Predictors of Arrhythmic and Cardiovascular Risk in End Stage Renal Disease study. Nephrol Dial Transplant 2019;34:346-54
  5. Ritz E, Wanner C. Lipid abnormalities and cardiovascular risk in renal disease. J Am Soc Nephrol 2008;19:1065-70
  6. Wan K, Zhao J, Huang H, Zhang Q, Chen X, Zeng Z, et al. The association between triglyceride/high-density lipoprotein cholesterol ratio and all-cause mortality in acute coronary syndrome after coronary revascularization. PLoS One 2015;10:e0123521
  7. Moriyama K. Associations Between the Triglyceride to High- Density Lipoprotein Cholesterol Ratio and Metabolic Syndrome, Insulin Resistance, and Lifestyle Habits in Healthy Japanese. Metab Syndr Relat Disord 2020;18:260-6
  8. Young KA, Maturu A, Lorenzo C, Langefeld CD, Wagenknecht LE, Chen YI, et al. The triglyceride to high-density lipoprotein cholesterol (TG/HDL-C) ratio as a predictor of insulin resistance, β-cell function, and diabetes in Hispanics and African Americans. J Diabetes Complications 2019;33:118-22
  9. Vega GL, Barlow CE, Grundy SM, Leonard D, DeFina LF. Triglyceride-to-high-density-lipoprotein-cholesterol ratio is an index of heart disease mortality and of incidence of type 2 diabetes mellitus in men. J Investig Med 2014;62:345-9
  10. Yeom H, Kim HC, Lee JM, Jeon Y, Suh I. Triglyceride to high density lipoprotein cholesterol ratio among adolescents is associated with adult hypertension: the Kangwha study. Lipids Health Dis 2018;17:212
  11. Bittner V, Johnson BD, Zineh I, Rogers WJ, Vido D, Marroquin OC, et al. The triglyceride/high-density lipoprotein cholesterol ratio predicts all-cause mortality in women with suspected myocardial ischemia: a report from the